Patents/Assignees

Avencell Europe GmbH

2 patents in portfolio

US12173063utility2024
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer, Infections and Autoimmune Disorders
0 cites
US11560426utility2023
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer Infections and Autoimmune Disorders
0 cites